Research graph
References from RNA replication-independent, DNA linearization-dependent expression of reporter genes from a SARS-CoV-2 replicon-encoding DNA in human cells. Local targets link to admitted publications; unresolved targets remain external evidence.
Characteristics of SARS-CoV-2 and COVID-19
10.1038/s41579-020-00459-7 · 2021 · External reference
Long COVID: major findings, mechanisms and recommendations
10.1038/s41579-022-00846-2 · 2023 · External reference
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
10.3389/fimmu.2022.945930 · 2022 · External reference
Therapeutic strategies for COVID-19: progress and lessons learned
10.1038/s41573-023-00672-y · 2023 · External reference
Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan
2024 · External reference
Biospecimen Collection During the COVID-19 Pandemic
10.1093/ajcp/aqaa171 · 2021 · External reference
Development of novel SARS-CoV-2 viral vectors
10.1038/s41598-023-40370-8 · 2023 · External reference
Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
10.3390/v12060598 · 2020 · External reference
Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening
10.1016/j.virol.2006.10.016 · 2007 · External reference
Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
10.1007/s12250-020-00341-z · 2021 · External reference
A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis
10.1016/j.csbj.2022.08.044 · 2022 · External reference
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
10.1016/j.jviromet.2023.114835 · 2023 · External reference
In Vitro Reversible Translation Control Using gammaPNA Probes
10.1021/jacs.5b05351 · 2015 · External reference
Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection
10.1128/jvi.02583-14 · 2015 · External reference
Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner
10.1128/jvi.80.4.2051-2054.2006 · 2006 · External reference
HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state
10.1371/journal.ppat.1007398 · 2018 · External reference
A novel aminoacid determinant of HIV-1 restriction in the TRIM5alpha variable 1 region isolated in a random mutagenic screen
10.1016/j.virusres.2013.01.013 · 2013 · External reference
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
2021 · External reference
SUMO-3 promotes the ubiquitin-dependent turnover of TRIM55
10.1139/bcb-2023-0153 · 2024 · External reference
T7 RNA polymerase cannot transcribe through a highly knotted DNA template
10.1093/nar/24.24.4890 · 1996 · External reference
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus
10.1128/jvi.62.12.4439-4444.1988 · 1988 · External reference
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
10.1038/s41598-021-82055-0 · 2021 · External reference
Reverse genetic systems of SARS-CoV-2 for antiviral research
10.1016/j.antiviral.2022.105486 · 2023 · External reference
Replication and single-cycle delivery of SARS-CoV-2 replicons
10.1126/science.abj8430 · 2021 · External reference
A novel cell culture system modeling the SARS-CoV-2 life cycle
10.1371/journal.ppat.1009439 · 2021 · External reference
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
10.1016/j.cell.2021.02.044 · 2021 · External reference
Construction of Stable T7 Expression System in Saccharomyces cerevisiae by Improving Nuclear Membrane Permeability with Viroporin HIV-1 Vpu
10.1007/s12010-021-03665-y · 2021 · External reference
Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
10.1128/jvi.73.1.251-259.1999 · 1999 · External reference
The development and applications of the bacterial artificial chromosome cloning system
10.2302/kjm.50.26 · 2001 · External reference
Human T lymphocyte genetic modification with naked DNA
10.1006/mthe.1999.0012 · 2000 · External reference
High spontaneous integration rates of end-modified linear DNAs upon mammalian cell transfection
10.1038/s41598-023-33862-0 · 2023 · External reference
Optimizing the generation of stable neuronal cell lines via pre-transfection restriction enzyme digestion of plasmid DNA
10.1007/s10616-010-9273-1 · 2010 · External reference
The coronavirus nucleocapsid is a multifunctional protein
10.3390/v6082991 · 2014 · External reference
Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
10.1128/jvi.00687-21 · 2021 · External reference
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization
10.1016/j.antiviral.2023.105744 · 2023 · External reference
Construction and characterization of two SARS-CoV-2 minigenome replicon systems
10.1002/jmv.27650 · 2022 · External reference
Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin
10.1002/jmv.29547 · 2024 · External reference
